• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Overdoses in youth with benzodiazepine and stimulant prescriptions

byAbdullah HaroonandAlex Gipsman, MD
March 17, 2022
in Chronic Disease, Pediatrics, Psychiatry, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. A retrospective analysis found that 29% of youth with benzodiazepine overdose and 25% of youth with stimulant overdose had a prescription dispensed in the last 30 days.

2. There was a higher proportion of intentional overdoses with recent benzodiazepine or stimulant prescriptions, and affected youth were more likely to be female than male.

 Evidence level: 2 (good)

 Study Rundown: Between 2015-2018, more than 10% of U.S youth and young adults simultaneously used two or more psychoactive prescription medications. This retrospective study used an insurance claims database to assess the prevalence of benzodiazepine (BZD) and stimulant prescriptions in youth treated for an overdose of these substances. Nearly 3,000 youth who experienced a BZD overdose and 971 youth with a stimulant overdose were included in the study. 42% of youth with BZD overdoses and 39% of youth with stimulant overdoses had a prescription dispensed in the previous 6 months. Depression and anxiety disorders were the most common mental health diagnoses in those with BZD overdoses whereas ADHD was most common amongst those with stimulant overdoses. A strength of this study is that it stratifies results between intentional self-harm versus accidental overdoses, helping prioritize targets for intervention. However, the retrospective study design, use of private insurance-based data, and exclusion of non-hospital-based overdoses and unreported fatal overdoses are major limitations. Overall, this study highlights the significant prevalence of recent prescriptions amongst youth who experience BZD and stimulant overdoses.

Click here to read the original article in Pediatrics

Relevant reading: Medical use and misuse of psychoactive prescription medications among US youth and young adults

In-depth [retrospective cohort]: This is a retrospective study analyzing data from MarketScan commercial claims between January 1, 2016, and December 31, 2018. Individuals aged 15-24 who had >6 months of insurance enrolment with prescription coverage and who had overdoses treated in the emergency room or as an inpatient were included in the study. The primary variable of interest was the proportion of youth with BZD or stimulant (methylphenidate or amphetamine) prescription prior to a first-time overdose. Results were divided between intentional and accidental overdoses. 29% of youth with BZD overdoses and 25% youth with stimulant overdose had a prescription in the previous 30 days. Within the stimulant category, overdoses involving methylphenidate were more common (64.4%) compared to those due to amphetamine (31.8%). Amongst youth with BZD or stimulant prescriptions in the previous 6 months, 73% had an anxiety disorder diagnosis and 71% had an ADHD diagnosis. Youth with a BZD overdose had a median age at overdose of 20 years, with intentional overdoses being more prevalent in females (62.8%) than males (p<0.001). Youth with a stimulant overdose had a median age at overdose of 19 years with an intentional overdose being more common in females (54.2%) than males (p<0.001).

RELATED REPORTS

Multiple factors impact racial and ethnic disparities in opioid use disorder treatment during pregnancy

Kratom use disorder and withdrawal may be common in the United States

United States veterans experiencing homelessness may have difficulty accessing secure messaging from providers

Image: PD ©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: addictionbenzodiazepinesdrug overdosestimulants
Previous Post

Breast cancer overdiagnosis rates not as high as estimated previously

Next Post

Systematic review and meta-analysis of statin-induced reduction in LDL-C demonstrates modest absolute benefits

RelatedReports

2 Minute Rewind November 29, 2021
Obstetrics

Multiple factors impact racial and ethnic disparities in opioid use disorder treatment during pregnancy

March 22, 2022
Galcanezumab reduces the frequency of episodic cluster headaches
Public Health

Kratom use disorder and withdrawal may be common in the United States

March 21, 2022
2 Minute Medicine Rewind October 21, 2019
Wellness

United States veterans experiencing homelessness may have difficulty accessing secure messaging from providers

February 8, 2022
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Chronic Disease

Psychosocial barriers may hinder expanded buprenorphine access amongst opioid use disorder patients

February 4, 2022
Next Post
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Systematic review and meta-analysis of statin-induced reduction in LDL-C demonstrates modest absolute benefits

Large spike in drug use-associated infective endocarditis linked with opioid epidemic

Accessible hepatitis C care for people who inject drugs provide significantly higher rates of cure compared to conventional care

2 Minute Medicine Rewind October 21, 2019

Telehealth may increase access to substance use treatment during COVID-19

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.